Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tempus AI, Inc. - Class A Common Stock
(NQ:
TEM
)
50.47
-0.82 (-1.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tempus AI, Inc. - Class A Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
Today 8:30 EDT
From
Tempus AI, Inc.
Via
Business Wire
What to Know About This Fund's $32.6 Million Porch Group Purchase
↗
May 30, 2026
This technology-driven firm delivers software and insurance solutions for home services professionals, homebuyers, and homeowners.
Via
The Motley Fool
Topics
Regulatory Compliance
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
May 30, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus AI Inc. (NASDAQ:TEM) Tumbles After Q1 Revenue Miss Despite EPS Beat and Raised Guidance
↗
May 05, 2026
Via
Chartmill
Topics
Artificial Intelligence
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
May 30, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology
May 29, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio
May 29, 2026
From
Tempus AI, Inc.
Via
Business Wire
Why Is Tempus AI Stock Surging On Thursday?
↗
May 28, 2026
Discover why Tempus AI Inc (NASDAQ:TEM) stock is surging today following major platform expansions and landmark clinical data ahead of ASCO 2026.
Via
Benzinga
Topics
Artificial Intelligence
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
↗
May 28, 2026
The widely followed growth investor keeps making moves.
Via
The Motley Fool
Topics
Artificial Intelligence
Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology
May 28, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows
May 27, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting
May 26, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use
May 21, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience
May 14, 2026
From
Tempus AI, Inc.
Via
Business Wire
TechMediaBreaks – MindBio Therapeutics Corp. (CSE: MBIO; Frankfurt: WF6; OTCQB: MBQIF) Advances AI Voice-Based Intoxication Detection as Real-Time Diagnostics Market Expands
May 11, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
The Future of Intoxication Detection May Be in Your Voice
May 11, 2026
Via
Investor Brand Network
Topics
Artificial Intelligence
Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”
May 11, 2026
From
Ambry Genetics
Via
Business Wire
3 Stocks Poised to Disrupt the Healthcare Market by 2030
↗
May 08, 2026
The old healthcare model is breaking down.
Via
The Motley Fool
Topics
Artificial Intelligence
The Future of Intoxication Detection May Be in Your Voice
May 11, 2026
From
BioMedWire
Via
GlobeNewswire
Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes
May 08, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense
May 07, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus AI (TEM) Q1 2026 Earnings Transcript
↗
May 05, 2026
Tempus AI (TEM) Q1 2026 Earnings Transcript
Via
The Motley Fool
Topics
Artificial Intelligence
Tempus Reports First Quarter 2026 Results
May 05, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus to Host Inaugural Investor Day on May 29, 2026
April 29, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026
April 28, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine
April 23, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus to Report First Quarter 2026 Financial Results on May 5
April 21, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
April 15, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
April 14, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care
April 13, 2026
From
Tempus AI, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.